Deleterious effects of soluble amyloid-β oligomers on multiple steps of synaptic vesicle trafficking

Neurobiology of Disease

Volumn 55, Issue , 2013, Pages 129-139

  Park, Joohyun ^a   Jang, Mirye ^a,b   Chang, Sunghoe ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Alzheimer's disease; Cyclin dependent kinase 5 (CDK5); Phosphatidylinositol 4,5 bisphosphate (PtdIns(4,5)P2); Soluble A oligomers; Synaptic vesicle trafficking

Indexed keywords

AMYLOID BETA OLIGOMER; AMYLOID BETA PROTEIN; CALPAIN; CYCLIN DEPENDENT KINASE 5; PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE TYPE 1 GAMMA; PHOSPHATIDYLINOSITOL 4 PHOSPHATE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL INCLUSION; CELL MIGRATION; CONTROLLED STUDY; EMBRYO; ENDOCYTOSIS; ENZYME INHIBITION; FEMALE; HIPPOCAMPUS; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT; READILY RELEASABLE POOL; RECYCLING POOL; RESTING POOL; SYNAPSE VESICLE;

AMYLOID BETA-PEPTIDES; ANIMALS; CALPAIN; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 5; EMBRYO, MAMMALIAN; ENDOCYTOSIS; FEMALE; HIPPOCAMPUS; NEURONS; PHOSPHATIDYLINOSITOL PHOSPHATES; PREGNANCY; PROBABILITY; PYRIDINIUM COMPOUNDS; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC VESICLES; TIME FACTORS; TRANSFECTION; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1;

EID: 84877625957     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.03.004     Document Type: Article

References (66)

1. Abramov E., et al. Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses. Nat. Neurosci. 2009, 12:1567-1576.
2. Ahn K.J., et al. Amino acid sequence motifs and mechanistic features of the membrane translocation of alpha-synuclein. J. Neurochem. 2006, 97:265-279.
3. Balaji J., Ryan T.A. Single-vesicle imaging reveals that synaptic vesicle exocytosis and endocytosis are coupled by a single stochastic mode. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:20576-20581.
4. Berman D.E., et al. Oligomeric amyloid-beta peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism. Nat. Neurosci. 2008, 11:547-554.
5. Billings L.M., et al. Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 2005, 45:675-688.
6. Burrone J., et al. Studying vesicle cycling in presynaptic terminals using the genetically encoded probe synaptopHluorin. Nat. Protoc. 2006, 1:2970-2978.
7. Calabrese B., et al. Rapid, concurrent alterations in pre- and postsynaptic structure induced by naturally-secreted amyloid-beta protein. Mol. Cell. Neurosci. 2007, 35:183-193.
8. Celsi F., et al. Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress. Neurobiol. Dis. 2007, 26:342-352.
9. Chang S., De Camilli P. Glutamate regulates actin-based motility in axonal filopodia. Nat. Neurosci. 2001, 4:787-793.
10. Chin J., et al. Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice. J. Neurosci. 2004, 24:4692-4697.
11. Cleary J.P., et al. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat. Neurosci. 2005, 8:79-84.
12. Cruz J.C., et al. p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo. J. Neurosci. 2006, 26:10536-10541.
13. Dahlgren K.N., et al. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J. Biol. Chem. 2002, 277:32046-32053.
14. Del Castillo J., Katz B. Quantal components of the end-plate potential. J. Physiol. 1954, 124:560-573.
15. Demuro A., et al. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 2005, 280:17294-17300.
16. Di Paolo G., et al. Impaired PtdIns(4,5)P2 synthesis in nerve terminals produces defects in synaptic vesicle trafficking. Nature 2004, 431:415-422.
17. Dittman J., Ryan T.A. Molecular circuitry of endocytosis at nerve terminals. Annu. Rev. Cell Dev. Biol. 2009, 25:133-160.
18. Dodart J.C., et al. Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. Nat. Neurosci. 2002, 5:452-457.
19. Granseth B., Lagnado L. The role of endocytosis in regulating the strength of hippocampal synapses. J. Physiol. 2008, 586:5969-5982.
20. Granseth B., et al. Clathrin-mediated endocytosis is the dominant mechanism of vesicle retrieval at hippocampal synapses. Neuron 2006, 51:773-786.
21. Green K.N., LaFerla F.M. Linking calcium to Abeta and Alzheimer's disease. Neuron 2008, 59:190-194.
22. Haass C., Selkoe D.J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 2007, 8:101-112.
23. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
24. Hsieh H., et al. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 2006, 52:831-843.
25. Itoh T., et al. Dynamin and the actin cytoskeleton cooperatively regulate plasma membrane invagination by BAR and F-BAR proteins. Dev. Cell 2005, 9:791-804.
26. Kelly B.L., Ferreira A. Beta-amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons. Neuroscience 2007, 147:60-70.
27. Kim S.H., Ryan T.A. CDK5 serves as a major control point in neurotransmitter release. Neuron 2010, 67:797-809.
28. Kim W.T., et al. Delayed reentry of recycling vesicles into the fusion-competent synaptic vesicle pool in synaptojanin 1 knockout mice. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:17143-17148.
29. Kim S., et al. Regulation of transferrin recycling kinetics by PtdIns[4,5]P2 availability. FASEB J. 2006, 20:2399-2401.
30. Klyubin I., et al. Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. Nat. Med. 2005, 11:556-561.
31. Kotilinek L.A., et al. Reversible memory loss in a mouse transgenic model of Alzheimer's disease. J. Neurosci. 2002, 22:6331-6335.
32. Lambert M.P., et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:6448-6453.
33. Lauren J., et al. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009, 457:1128-1132.
34. Lee M.S., et al. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 2000, 405:360-364.
35. Lee V.M., et al. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 2001, 24:1121-1159.
36. Lee S., et al. SPIN90/WISH interacts with PSD-95 and regulates dendritic spinogenesis via an N-WASP-independent mechanism. EMBO J. 2006, 25:4983-4995.
37. Lee H.J., et al. Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. Int. J. Biochem. Cell Biol. 2008, 40:1835-1849.
38. McLean C.A., et al. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol. 1999, 46:860-866.
39. Miesenbock G., et al. Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins. Nature 1998, 394:192-195.
40. Moreno H., et al. Synaptic transmission block by presynaptic injection of oligomeric amyloid beta. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:5901-5906.
41. Murthy V.N., De Camilli P. Cell biology of the presynaptic terminal. Annu. Rev. Neurosci. 2003, 26:701-728.
42. Murthy V.N., Stevens C.F. Reversal of synaptic vesicle docking at central synapses. Nat. Neurosci. 1999, 2:503-507.
43. Nimmrich V., et al. Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. J. Neurosci. 2008, 28:788-797.
44. Oliveira T.G., et al. Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits. J. Neurosci. 2010, 30:16419-16428.
45. Palop J.J., Mucke L. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat. Neurosci. 2010, 13:812-818.
46. Patrick G.N., et al. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 1999, 402:615-622.
47. Praefcke G.J., McMahon H.T. The dynamin superfamily: universal membrane tubulation and fission molecules?. Nat. Rev. Mol. Cell Biol. 2004, 5:133-147.
48. Puzzo D., et al. Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J. Neurosci. 2008, 28:14537-14545.
49. Qu J., et al. S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:14330-14335.
50. Roux A., et al. GTP-dependent twisting of dynamin implicates constriction and tension in membrane fission. Nature 2006, 441:528-531.
51. Ryan T.A., Smith S.J. Vesicle pool mobilization during action potential firing at hippocampal synapses. Neuron 1995, 14:983-989.
52. Sankaranarayanan S., Ryan T.A. Real-time measurements of vesicle-SNARE recycling in synapses of the central nervous system. Nat. Cell Biol. 2000, 2:197-204.
53. Sankaranarayanan S., Ryan T.A. Calcium accelerates endocytosis of vSNAREs at hippocampal synapses. Nat. Neurosci. 2001, 4:129-136.
54. Sankaranarayanan S., et al. The use of pHluorins for optical measurements of presynaptic activity. Biophys. J. 2000, 79:2199-2208.
55. Schikorski T., Stevens C.F. Morphological correlates of functionally defined synaptic vesicle populations. Nat. Neurosci. 2001, 4:391-395.
56. Shankar G.M., et al. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J. Neurosci. 2007, 27:2866-2875.
57. Shin N., et al. Sorting nexin 9 interacts with dynamin 1 and N-WASP and coordinates synaptic vesicle endocytosis. J. Biol. Chem. 2007, 282:28939-28950.
58. Snyder E.M., et al. Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 2005, 8:1051-1058.
59. Takei K., Haucke V. Clathrin-mediated endocytosis: membrane factors pull the trigger. Trends Cell Biol. 2001, 11:385-391.
60. Takei K., et al. Functional partnership between amphiphysin and dynamin in clathrin-mediated endocytosis. Nat. Cell Biol. 1999, 1:33-39.
61. Um J.W., et al. Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat. Neurosci. 2012, 15:1227-1235.
62. Voglmaier S.M., et al. Distinct endocytic pathways control the rate and extent of synaptic vesicle protein recycling. Neuron 2006, 51:71-84.
63. Walsh D.M., et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002, 416:535-539.
64. Walsh D.M., et al. Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem. Soc. Trans. 2002, 30:552-557.
65. Wenk M.R., et al. PIP kinase Igamma is the major PI(4,5)P(2) synthesizing enzyme at the synapse. Neuron 2001, 32:79-88.
66. Zucker R.S., Regehr W.G. Short-term synaptic plasticity. Annu. Rev. Physiol. 2002, 64:355-405.